From: DNA methylation and hormone receptor status in breast cancer
Total (N = 75) | ER/PR positive | |||
---|---|---|---|---|
N | % | % | P value (chi-square test) | |
Age at diagnosis | 0.88 | |||
<50 | 20 | 27 | 75 | |
50–59 | 20 | 27 | 70 | |
60–79 | 35 | 47 | 69 | |
Race/ethnicity | 0.44 | |||
nH Black | 31 | 41 | 65 | |
nH White | 21 | 28 | 81 | |
Hispanic | 23 | 31 | 70 | |
Pathological stage | 0.39 | |||
1 | 23 | 31 | 83 | |
2 | 33 | 44 | 67 | |
3 | 18 | 24 | 61 | |
4 | 1 | 1 | 100 | |
Histologic grade | 0.10 | |||
Low | 5 | 7 | 100 | |
Moderate | 31 | 42 | 77 | |
High | 38 | 51 | 61 | |
1st degree familial breast cancer | 0.25 | |||
None | 50 | 68 | 68 | |
Moderate | 18 | 24 | 67 | |
Strong (<50/multiple affected) | 6 | 8 | 100 |